top of page
  • Lloyd Price

Wound Care: Emerging HealthTech market with $27.2 billion projected value by 2027



Exec Summary:

The wound care market is a rapidly growing market, with a projected value of $27.2 billion by 2027. This growth is being driven by a number of factors, including the increasing prevalence of chronic wounds, the aging population, and technological advances in wound care.


Some of the emerging technologies in wound care include:

  • Nanotechnology: Nanotechnology is being used to develop new wound dressings that can deliver drugs and other therapies directly to the wound site.

  • Stem cell therapy: Stem cell therapy is being investigated as a potential treatment for chronic wounds. Stem cells have the ability to differentiate into different types of cells, including skin cells, which could help to regenerate damaged tissue.

  • Bioengineered skin grafts: Bioengineered skin grafts are being developed that can be used to replace damaged skin. These grafts are made from a patient's own cells, which reduces the risk of rejection.

  • 3D printing: 3D printing is being used to create customized wound dressings that fit the specific needs of each patient.

These are just a few of the emerging technologies in wound care. As these technologies continue to develop, they have the potential to revolutionize the way that wounds are treated.


Here are some additional details about each of these emerging technologies:

  • Nanotechnology: Nanotechnology is the use of materials and devices at the nanoscale (1-100 nanometers). Nanoparticles can be used to deliver drugs and other therapies directly to the wound site. This can be beneficial because it can help to increase the effectiveness of the therapy and reduce the side effects. Nanoparticles can also be used to create wound dressings that are more absorbent and resistant to infection.

  • Stem cell therapy: Stem cells are undifferentiated cells that have the potential to develop into different types of cells. Stem cells can be used to regenerate damaged tissue, including skin tissue. Stem cell therapy is still in its early stages, but it has the potential to be a very effective treatment for chronic wounds.

  • Bioengineered skin grafts: Bioengineered skin grafts are made from a patient's own cells. These grafts are grown in the lab and then transplanted onto the patient's wound. Bioengineered skin grafts are more likely to be accepted by the patient's body than traditional skin grafts.

  • 3D printing: 3D printing is a process that can be used to create three-dimensional objects from a digital file. 3D printing is being used to create customized wound dressings that fit the specific needs of each patient. These dressings can be designed to provide the optimal level of protection, absorption, and moisture control.

These are just a few of the emerging technologies that have the potential to revolutionize the way that wounds are treated. As these technologies continue to develop, they have the potential to improve the healing time of wounds and reduce the risk of complications.


Engage with the HealthTech Community


HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb


HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk


HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital


Innovative wound care technology companies


Some of the most innovative wound care technology companies currently on the market include:

  • ACell: ACell develops and markets products that use stem cells to treat chronic wounds. The company's products include ACell Wound Matrix, which is a bioengineered skin substitute, and ACell Wound Care System, which is a device that delivers stem cells directly to the wound site.

  • ConvaTec: ConvaTec is a global medical device company that develops and markets a wide range of wound care products. The company's products include dressings, bandages, and negative pressure wound therapy devices.

  • Derma Sciences: Derma Sciences is a medical device company that develops and markets products for the treatment of chronic wounds. The company's products include Acticoat, which is a silver dressing that helps to kill bacteria, and Dermagraft, which is a bioengineered skin substitute.

  • Integra LifeSciences: Integra LifeSciences is a medical device company that develops and markets products for the treatment of chronic wounds. The company's products include Integra Dermal Regeneration Template, which is a bioengineered skin substitute, and PriMatrix, which is a collagen matrix that helps to promote wound healing.

  • Molnlycke Health Care: Mölnlycke Health Care is a Swedish medical device company that develops and markets a wide range of wound care products. The company's products include Mepilex Border Flex, which is a dressing that helps to keep wounds moist, and Tegaderm, which is a transparent film dressing that protects wounds from bacteria.

These are just a few of the many innovative wound care technology companies that are working to develop new and improved products to help patients heal more quickly and effectively.


Wound Care funding and startups


Grand View Research report highlights the fact there was over $1.3 billion invested in wound care startups in 2021 and 2022. This investment is being driven by a number of factors, including:

  • The increasing prevalence of chronic wounds.

  • The aging population.

  • Technological advances in wound care.

  • The potential for new and improved products to improve patient outcomes.


In 2021, there was $750 million invested in wound care startups. Some of the notable investments in 2021 include:

  • HealSkin: This company received $10 million in Series A funding to develop a bioengineered skin substitute that can be used to treat chronic wounds.

  • NuVision Biotherapies: This company received £500,000 in funding to develop a groundbreaking therapy that can help prevent sight loss. The therapy uses amniotic tissue to regenerate damaged tissue.

  • BioMonde: This company received £3.5 million in funding to develop a new treatment for hard-to-treat wounds. The treatment uses maggots to debride the wound and promote healing.

In 2020, there was $600 million invested in wound care startups. Some of the notable investments in 2020 include:

  • The Wound Company: This company received $4.25 million in seed funding to develop a platform that connects providers with wound care specialists to treat patients with chronic wounds.

  • Fibroheal: This company received a follow-on investment of Rs 2.25 crore to scale up its manufacturing capacity and expand its distribution network. Fibroheal develops silk protein-based wound management solutions.

  • ACell: This company received $25 million in Series C funding to develop and commercialise its bioengineered skin substitute.

As you can see, there has been a significant amount of investment in wound care startups in recent years. This investment is being driven by the growing market for wound care products and services, as well as the innovative technologies that are being developed in this space.


Future of wound care innovation


There are a number of promising technologies in development that have the potential to revolutionize the way that wounds are treated.

Some of the most promising technologies include:

  • Bioengineered skin substitutes: These products are made from a patient's own cells or from donated cells. They can be used to replace damaged skin and promote healing.

  • Negative pressure wound therapy: This therapy uses negative pressure to remove fluid and bacteria from a wound. This can help to promote healing and prevent infection.

  • Wound dressings: New wound dressings are being developed that can deliver drugs and other therapies directly to the wound site. This can help to improve the effectiveness of treatment and reduce the risk of side effects.

  • Wound sensors: These sensors can be used to monitor the healing progress of a wound and track the effectiveness of treatment. This information can be used to personalize treatment and improve outcomes.

  • Wound imaging: New imaging technologies are being developed that can provide detailed images of wounds. This information can be used to diagnose the cause of the wound and assess the healing progress.

These are just a few of the many promising technologies that are being developed in the field of wound care. As these technologies continue to develop, there is the potential to revolutionize the way that wounds are treated and improve patient outcomes.

Here are some additional thoughts on the future of wound care innovation:

  • Theranostics: Theranostics is a combination of therapy and diagnostics. This approach has the potential to revolutionize wound care by providing personalized treatment that is tailored to the specific needs of each patient.

  • Precision medicine: Precision medicine is an approach to medicine that takes into account individual patient characteristics, such as genetics, environment, and lifestyle. This approach has the potential to improve the effectiveness of wound care by ensuring that patients receive the right treatment for their specific needs.

  • Artificial intelligence: Artificial intelligence is being used in a variety of fields, including wound care. AI can be used to analyze data from wound sensors and imaging technologies to provide insights into the healing process. This information can be used to personalize treatment and improve outcomes.

The future of wound care innovation is exciting. As these technologies continue to develop, there is the potential to revolutionize the way that wounds are treated and improve patient outcomes.


Engage with the HealthTech Community


HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb


HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk


HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital



42 views
Screenshot 2023-11-06 at 13.13.55.png
bottom of page